机译:Physiology‐based pharmacokinetic modelling and experimental data suggest that rifabutin alters dolutegravir kinetics by both P‐glycoprotein induction and concurrent inhibition
Department of Clinical Pharmacology and Pharmacoepidemiology,Heidelberg University Hospital;
dolutegravir; drug–drug interactions; P‐glycoprotein (P‐gp); physiology‐based pharmacokinetics; population pharmacokinetics; rifabutin;